Cargando…

Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein

BACKGROUND: Contrast-enhanced ultrasound (CEUS) can be used to diagnose focal liver lesions (FLLs) in children. The America College of Radiology developed the CEUS liver imaging reporting and data system (LI-RADS) for standardizing CEUS diagnosis of FLLs in adult patients. Until now, no similar cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Zhen-Peng, Zeng, Ke-Yu, Huang, Jia-Yan, Yang, Jie, Yang, Rui, Li, Jia-Wu, Qiu, Ting-Ting, Luo, Yan, Lu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185218/ https://www.ncbi.nlm.nih.gov/pubmed/35800178 http://dx.doi.org/10.3748/wjg.v28.i21.2350

Ejemplares similares

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
por: Wen, Rong, et al.
Publicado: (2023)

CEUS LI-RADS: a pictorial review
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2020)

R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions
por: Shi, Guang-Zi, et al.
Publicado: (2021)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
por: Wang, Peihua, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
por: Zhou, Yan, et al.
Publicado: (2022)

Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
por: Rungsakulkij, Narongsak, et al.
Publicado: (2018)

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study
por: Strobel, D., et al.
Publicado: (2021)

Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk
por: Tong, Wen-juan, et al.
Publicado: (2022)

Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation
por: Matsumoto, Kohei, et al.
Publicado: (2016)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size
por: Zhu, Jianing, et al.
Publicado: (2022)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125
por: Yu, Kang, et al.
Publicado: (2021)

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Predictive value of serum alpha-fetoprotein for tumor regression after preoperative chemotherapy for rectal cancer
por: Zhang, Da-Kui, et al.
Publicado: (2022)

Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer
por: Jiao, Hong-Bin, et al.
Publicado: (2022)

Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
por: Carrier, Paul, et al.
Publicado: (2021)

The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm)
por: Ling, Wenwu, et al.
Publicado: (2018)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: From static images to CEUS video analysis
por: Zhu, Jun-Yan, et al.
Publicado: (2022)

Comparison of machine learning models and CEUS LI-RADS in differentiation of hepatic carcinoma and liver metastases in patients at risk of both hepatitis and extrahepatic malignancy
por: Li, Jianming, et al.
Publicado: (2023)

Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2017)

Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
por: She, Wong Hoi, et al.
Publicado: (2018)

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
por: Zhang, Tong, et al.
Publicado: (2019)

Central pancreatectomy for benign or low-grade malignant pancreatic tumors in the neck and body of the pancreas
por: Chen, Yi-Wen, et al.
Publicado: (2022)

Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

Correction to: Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

Deep Neural Architectures for Contrast Enhanced Ultrasound (CEUS) Focal Liver Lesions Automated Diagnosis †
por: Căleanu, Cătălin Daniel, et al.
Publicado: (2021)

Focal Lesions in Fatty Liver: If Quantitative Analysis Facilitates the Differentiation of Atypical Benign from Malignant Lesions
por: Shan, Quan-Yuan, et al.
Publicado: (2016)

Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules
por: Zhang, Yan, et al.
Publicado: (2016)

Structured Reporting Using CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma (HCC)—Impact and Advantages on Report Integrity, Quality and Interdisciplinary Communication
por: Geyer, Thomas, et al.
Publicado: (2021)

Contrast-Enhanced Ultrasonography for Differential Diagnosis of Benign and Malignant Thyroid Lesions: Single-Institutional Prospective Study of Qualitative and Quantitative CEUS Characteristics
por: Petrasova, Hana, et al.
Publicado: (2022)

Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomography
por: Cao, Su-E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_363g6ljng2lbrh6rf1k20u3m7j